RELAY THERAPEUTICS INC's ticker is RLAY and the CUSIP is 75943R102. A total of 125 filers reported holding RELAY THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $8,557,862 | -41.5% | 1,017,668 | -12.6% | 0.00% | -40.0% |
| Q2 2023 | $14,625,712 | -28.1% | 1,164,386 | -5.8% | 0.01% | -28.6% |
| Q1 2023 | $20,351,153 | +128590.7% | 1,235,795 | +16.7% | 0.01% | +40.0% |
| Q4 2022 | $15,814 | -99.9% | 1,058,543 | +66.5% | 0.01% | 0.0% |
| Q3 2022 | $14,220,000 | +115.6% | 635,607 | +61.4% | 0.01% | +150.0% |
| Q2 2022 | $6,595,000 | +280.6% | 393,791 | +580.5% | 0.00% | +100.0% |
| Q1 2022 | $1,733,000 | +660.1% | 57,866 | +827.9% | 0.00% | – |
| Q2 2021 | $228,000 | +5.6% | 6,236 | 0.0% | 0.00% | – |
| Q1 2021 | $216,000 | – | 6,236 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Casdin Capital, LLC | 3,030,648 | $45,277,881 | 3.51% |
| SB INVESTMENT ADVISERS (UK) LTD | 27,904,963 | $416,900,147 | 3.48% |
| Finepoint Capital LP | 714,848 | $10,680 | 3.45% |
| Nextech Invest Ltd. | 475,485 | $7,103,746 | 2.83% |
| BVF INC/IL | 3,876,021 | $57,907,754 | 2.44% |
| Integral Health Asset Management, LLC | 625,000 | $9,337,500 | 1.96% |
| EcoR1 Capital, LLC | 4,163,824 | $62,207,531 | 1.89% |
| Boxer Capital, LLC | 2,169,132 | $32,406,832 | 1.71% |
| BRANDYWINE MANAGERS, LLC | 31,807 | $475,197 | 1.66% |
| HighVista Strategies LLC | 176,521 | $2,637,224 | 1.57% |